Subject(s)
Cicatrix , Mohs Surgery , Surgical Wound , Timolol , Humans , Mohs Surgery/adverse effects , Timolol/administration & dosage , Timolol/therapeutic use , Female , Male , Cicatrix/prevention & control , Cicatrix/etiology , Aged , Surgical Wound/surgery , Middle Aged , Adrenergic beta-Antagonists/therapeutic use , Adrenergic beta-Antagonists/administration & dosage , Skin Neoplasms/surgery , Wound Healing/drug effects , Aged, 80 and over , Treatment OutcomeSubject(s)
Psoriasis , Racial Groups , Ethnicity , Humans , Psoriasis/diagnosis , United States/epidemiologyABSTRACT
A 28-year-old African-American man presented for evaluation of an asymptomatic bump that had been present on his scalp for a few months. His past medical history included multiple ganglioneuromas of the gastrointestinal tract, several lipomas, and thyroidectomy for follicular thyroid carcinoma. His father had similar facial lesions and numerous lipomas. (SKINmed. 2021;19:-0).
Subject(s)
Hamartoma Syndrome, Multiple/diagnosis , Scalp/pathology , Adult , Hamartoma Syndrome, Multiple/pathology , Humans , MaleABSTRACT
Hidradenitis suppurativa (HS), a chronic, inflammatory, recurrent cutaneous disorder of the hair follicles, is debilitating and has substantial morbidity. Hidradenitis suppurativa-related pain has a profound effect on patient quality of life, yet at present, there are no established pain management algorithms. This comprehensive review provides an update on current treatment of HS-associated pain, including a summary of existing literature surrounding pharmacologic treatments of acute, perioperative, and chronic pain. Additionally, the epidemiology, pathophysiology, and clinical features of the disease are summarized.
